Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Trogarzo. Always confirm against the full prescribing information.
100 interactions
Adenovirus type 7 vaccine live
The therapeutic efficacy of Adenovirus type 7 vaccine live can be decreased when used in combination with Ibalizumab.
Level 2 evidence
Anthrax vaccine
The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Ibalizumab.
Level 2 evidence
Bacillus calmette-guerin substrain tice live antigen
The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Ibalizumab.
Level 2 evidence
Chikungunya vaccine (live, attenuated)
The therapeutic efficacy of Chikungunya vaccine (live, attenuated) can be decreased when used in combination with Ibalizumab.
Level 2 evidence
Human adenovirus e serotype 4 strain cl-68578 antigen
The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Ibalizumab.
Level 2 evidence
Adalimumab
The risk or severity of adverse effects can be increased when Adalimumab is combined with Ibalizumab.
Level 2 evidence
Aducanumab
The risk or severity of adverse effects can be increased when Aducanumab is combined with Ibalizumab.
Level 2 evidence
Alemtuzumab
The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Ibalizumab.
Level 2 evidence
Alirocumab
The risk or severity of adverse effects can be increased when Alirocumab is combined with Ibalizumab.
Level 2 evidence
Amivantamab
The risk or severity of adverse effects can be increased when Ibalizumab is combined with Amivantamab.
Level 2 evidence
Anifrolumab
The risk or severity of adverse effects can be increased when Anifrolumab is combined with Ibalizumab.
Level 2 evidence
Ansuvimab
The risk or severity of adverse effects can be increased when Ibalizumab is combined with Ansuvimab.
Level 2 evidence
Enter your NPI to unlock 2 major interactions for Trogarzo
Trogarzo (Ibalizumab) has 176 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Trogarzo (Ibalizumab) has 2 major, 13 moderate, and 161 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Trogarzo. Always confirm against the full prescribing information.